search
Documents
Nicotinic Acid and Nicotinamide in Human Plasma by LC/MS/MS (TN-1151)
Simple and Fast Quantitation of Nicotinic Acid and Nicotinamide in Human Plasma by Applying Impact™ Protein Precipitation Plate Technology with Gemini® 3 μm C18 HPLC Columns
Nicotinic Acid and Nicotinamide in Human Plasma by LC/MS/MS (TN-1151)
Simple and Fast Quantitation of Nicotinic Acid and Nicotinamide in Human Plasma by Applying Impact™ Protein Precipitation Plate Technology with Gemini® 3 μm C18 HPLC Columns
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Protein Precipitation, Reversed Phase
Phases:
Nicotinic Acid and Nicotinamide in Human Plasma by LC/MS/MS (TN-1151)
Simple and Fast Quantitation of Nicotinic Acid and Nicotinamide in Human Plasma by Applying Impact™ Protein Precipitation Plate Technology with Gemini® 3 μm C18 HPLC Columns
| Target Industries: | Biopharmaceutical Analysis, Clinical Research, Pharmaceutical |
| Techniques: | HPLC, HPLC Reversed Phase, Protein Precipitation, Sample Preparation |
| Brands: | Gemini, Impact Protein Precipitation Plates |
| Separation Modes: | Protein Precipitation, Reversed Phase |
| Phases: | Gemini C18 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.